Comparison of Choosing Free ALT or Free PMT for Reconstruction With Head and Neck Cancer

Comparison of the Outcome of Choosing Free Anterolateral Thigh or Free Posterolateral Thigh Flap for Reconstruction in Patients With Head and Neck Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04002713

Enrollment

1590

Registered

2019-07-01

Start date

2019-03-20

Completion date

2019-06-03

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer, Reconstructive Surgery

Keywords

Anterolateral thigh (ALT), anteromedial thigh (AMT), free flap reconstruction, microsurgery, head and neck cancer, outcomes

Brief summary

This study was designed to compare the outcome of the anteromedial thigh (AMT) and anterolateral thigh (ALT) flaps in head and neck cancer reconstruction.

Detailed description

To compare the results of the AMT and ALT flaps, this study aimed to compare their outcomes in head and neck cancer reconstruction under the condition of attenuating baseline patient and operative characteristics with the selection of propensity score-matched patient cohorts.

Interventions

OTHERALT flap reconstruction

Patients who underwent ALT free flap reconstruction after head and neck cancer surgery.

OTHERAMT flap reconstruction

Patients who underwent AMT free flap reconstruction after head and neck cancer surgery.

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Patients who underwent ALT or AMT free flap reconstruction after head and neck cancer surgery between March 1, 2008 and February 28, 2017.

Exclusion criteria

* Patients whose data were missing will be excluded.

Design outcomes

Primary

Measure	Time frame	Description
survival or failure	up to 6 months	The primary free flap outcome was determined as its survival or failure.

Secondary

Measure	Time frame	Description
Complications	up to 6 months	The second outcome was the associated complications (fistula, hematoma, partial necrosis, and wound infection).

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026